76 related articles for article (PubMed ID: 12068137)
1. Survival benefits of lung cancer patients undergoing laser and brachytherapy.
Jang TW; Blackman G; George JJ
J Korean Med Sci; 2002 Jun; 17(3):341-7. PubMed ID: 12068137
[TBL] [Abstract][Full Text] [Related]
2. Combination of interventional pulmonology techniques (Nd:YAG laser resection and brachytherapy) with external beam radiotherapy in the treatment of lung cancer patients with Karnofsky Index < or =50.
Canak V; Zarić B; Milovancev A; Jovanović S; Budisin E; Sarcev T; Lalić N; Nisević V; Balaban G
J BUON; 2006; 11(4):447-56. PubMed ID: 17309176
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
Spásová I; Petera J
Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295
[TBL] [Abstract][Full Text] [Related]
4. Endobronchial radiation therapy for obstructing malignancies: ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients.
Macha HN; Wahlers B; Reichle C; von Zwehl D
Lung; 1995; 173(5):271-80. PubMed ID: 7564485
[TBL] [Abstract][Full Text] [Related]
5. Bronchoscopic palliation of primary lung cancer: single or multimodality therapy?
Santos RS; Raftopoulos Y; Keenan RJ; Halal A; Maley RH; Landreneau RJ
Surg Endosc; 2004 Jun; 18(6):931-6. PubMed ID: 15108108
[TBL] [Abstract][Full Text] [Related]
6. [The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas].
Schraube P; Fritz P; Becker HD; Wannenmacher M
Strahlenther Onkol; 1993 Apr; 169(4):228-34. PubMed ID: 8387698
[TBL] [Abstract][Full Text] [Related]
7. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.
Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A
Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560
[TBL] [Abstract][Full Text] [Related]
8. Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma.
Miller JI; Phillips TW
Ann Thorac Surg; 1990 Aug; 50(2):190-5; discussion 195-6. PubMed ID: 1696452
[TBL] [Abstract][Full Text] [Related]
9. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
[TBL] [Abstract][Full Text] [Related]
10. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
11. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
Makarewicz R
Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
[TBL] [Abstract][Full Text] [Related]
12. A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.
Lee JS; Komaki R; Morice RC; Ro JY; Kalapurakal SK; Schea R; Murphy WK; Shin DM; Fox NT; Walsh GL; Hittelman WN; Hong WK
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):121-9. PubMed ID: 10210551
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in radiation therapy for non-small cell lung cancer].
Morita K
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():103-6. PubMed ID: 9216195
[TBL] [Abstract][Full Text] [Related]
14. The effect of Nd:YAG laser resection on symptom control, time to progression and survival in lung cancer patients.
Zaric B; Canak V; Milovancev A; Jovanovic S; Budisin E; Sarcev T; Nisevic V
J BUON; 2007; 12(3):361-8. PubMed ID: 17918290
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients undergoing Nd:YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease.
Shea JM; Allen RP; Tharratt RS; Chan AL; Siefkin AD
Chest; 1993 Apr; 103(4):1028-31. PubMed ID: 7510598
[TBL] [Abstract][Full Text] [Related]
16. Anatomic segmentectomy and brachytherapy mesh implantation for clinical stage I non-small cell lung cancer (NSCLC).
Landreneau JP; Schuchert MJ; Weyant R; Abbas G; Wizorek JJ; Awais O; Reamer MM; Luketich JD; Landreneau RJ
Surgery; 2014 Feb; 155(2):340-6. PubMed ID: 24314884
[TBL] [Abstract][Full Text] [Related]
17. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ
Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
19. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
20. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study.
Chella A; Ambrogi MC; Ribechini A; Mussi A; Fabrini MG; Silvano G; Cionini L; Angeletti CA
Lung Cancer; 2000 Mar; 27(3):169-75. PubMed ID: 10699690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
